Earnings was around Feb 8th last year, few more days for year end statement. Anyway, never buy this stock on earnings, 1st they still don't matter yet until $50 million qtr rev for E, 2nd it goes down when the earnings look good and it's a coin toss when the earnings look bad.
Well if this gets on the CHMP docket for february (middle of the month), I'd be watching for their PRAC meeting ahead of it earlier in february. That must occur first and is a sign for a CHMP meeting review. That PRAC meeting would occur first--look for their results to clue ya in on whether they get a February CHMP review!